Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Eyetelligence builds artificial intelligence screening software that detects glaucoma, diabetic retinopathy and macular degeneration from retinal images. Founded in 2018 in Melbourne, it received Australian regulatory clearance for clinical use. The software is designed for optometrists and primary care rather than specialist clinics.
News
Eyetelligence platform improves cataract surgery accuracy, safety
LOS ANGELES - Eyetelligence, a cloud-based cataract surgery planning platform, offers the opportunity to improve IOL power calculations and safety in the operating room, according to Mark C. Lobanoff, MD, ABO.At the American Society of Cataract and Refrac
Read more
Report
Bausch + Lomb introduces surgical planning software for Eyetelligence
Bausch + Lomb introduced new surgical planning software for the Eyetelligence platform.
Read more
Report
Bausch + Lomb Signs Deal With Lochan to Develop New eyeTELLIGENCE Clinical Decision Support Software
Bausch + Lomb, a global eye health business owned byBausch Health Companies Inc. (BHC), announced Tuesday that ithassigned a dealwith Lochan LLC.Thissoftware development companybrings new solutions to complexophthalmiccalculationsusingartificial intellige
Read more
Report
Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE Clinical Decision Support Software
LAVAL, QB and ST. PAUL, Minn., June 8, 2021/ PRNewswire/-- Bausch+ Lomb, a leading global eye health business of Bausch Health Companies Inc., today announced that its affiliate has entered into an agreement with Lochan LLC to develop the next-generation
Read more
Report